Pneumonia in the elderly patient

Infectious Diseases in Clinical Practice

Volumn 8, Issue 8, 1999, Pages 361-367

  Rhew, David C ^a   Goetz, Matthew Bidwell ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; INFLUENZA VACCINE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TROVAFLOXACIN; VANCOMYCIN;

AGED; CHLAMYDOPHILA PNEUMONIAE; COST EFFECTIVENESS ANALYSIS; GERIATRIC PATIENT; HEALTH CARE COST; HOST RESISTANCE; HUMAN; INFECTION RISK; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PNEUMONIA; PRACTICE GUIDELINE; SHORT SURVEY; STREPTOCOCCUS PNEUMONIAE;

EID: 0032737853     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199911000-00005     Document Type: Short Survey

References (51)

1. Marston BJ, Plouffe JF, File TMJ, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 1997;157:1709-18.
2. Koivula I, Sten M, Makela PH. Risk factors for pneumonia in the elderly. Am J Med 1994;96:313-20.
3. Kikuchi R, Watabe N, Konno T, et al. High incidence of silent aspiration in elderly patients with community-acquired pneumonia. Am J Respir Crit Case Med 1994;150:251-3.
4. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
5. Mehr DR, Foxman B, Colombo P. Risk factors for mortality from lower respiratory infections in nursing home patients. J Fam Pract 1992;34:585-91.
6. Fried TR, Gillick MR, Lipsitz LA. Whether to transfer? Factors associated with hospitalization and outcome of elderly long-term care patients with pneumonia. J Gen Intern Med 1995;10:246-50.
7. Muder RR, Brennen C, Swenson DL, et al. Pneumonia in a long-term care facility. A prospective study of outcome. Arch Intern Med 1996;156:2365-70.
8. Fine MJ, Hanusa BH, Lave JR, et al. Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia. J Gen Intern Med 1995;10:359-68.
9. Fine MJ, Singer DE, Hanusa BH, et al. Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. Am J Med 1998;94: 153-9.
10. Metlay JP, Schulz R, Li YH, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 1997;157:1453-9.
11. Shelhamer JH, Toews GB, Masur H, et al. Respiratory disease in the immunosuppressed patient. Ann Intern Med 1992;117:415-31.
12. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997;279:2080-4.
13. Riquelme R, Torres A, El-Ebiary M, et al. Community-acquired pneumonia in the elderly. Clinical and nutritional aspects. Am J Respir Crit Care Med 1997;156:1908-14.
14. Muder RR. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. Am J Med 1998;105:319-30.
15. Marrie TJ. Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly. Arch Intern Med 1993;153:488-94.
16. Myhra W, Mordhorst CH, Wang S-P. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. In Bowie WR, Caldwell HD, Jones RP, editors. Chlamydia infections. Cambridge, England: Cambridge University Press; 1980. p. 422-5.
17. Marrie TJ, Peeling RW, Fine MJ, et al. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med 1996; 101:508-15.
18. Lieberman D, Schlaeffer F, Porath A. Community-acquired pneumonia in old age: a prospective study of 91 patients admitted from home. Age Ageing 1997;26:69-75.
19. Orr PH, Peeling RW, Fast M, et al. Serological study of responses to selected pathogens causing respiratory tract infection in the institutionalized elderly. Clin Infect Dis 1996;23:1240-5.
20. Grayston JT, Aldous MB, Easton A, et al. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis 1993;168:1231-5.
21. Troy CJ, Peeling RW, Ellis AG, et al. Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes. JAMA 1997;277:1214-8.
22. Centers for Disease Control and Prevention. Prevention of pneumococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46(RR-8):1-24.
23. Plouffe JF, Breiman RF, Facklam RR. Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. JAMA 1996;275:194-8.
24. Sisk JE, Moskowitz AJ, Whang W, et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA 1997;278:1333-9.
25. Gennis P, Gallagher J, Falvo C, et al. Clinical criteria for the detection of pneumonia in adults: guidelines for ordering chest roentgenograms in the emergency department. J Emerg Med 1989;7:263-8.
26. Bartlett JG, Breiman RF, Mandell LA, et al. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998;26:811-38.
27. Coley CM, Li YH, Medsger AR, et al. Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia. Arch Intern Med 1996; 156:1565-71.
28. Zimmer JG, Eggert G, Treat A, et al. Nursing homes as acute care providers. A pilot study of incentives to reduce hospitalizations. J Am Geriatr Soc 1988;36:124-9.
29. Heath CH, Grove DI, Looke DF. Delay in appropriate therapy of legionella pneumonia associated with increased mortality. Eur J Clin Microbiol Infect Dis 1996; 15:286-90.
30. Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998; 113:412-20.
31. American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. AmJ Respir Crit Care Med 1996;153:1711-25.
32. Gordon GS, Throop D, Berberian L, Niederman M, Bass J, Alemayehu D, Mellis S. Validation of the therapeutic recommendations of the American Thoracic Society (ATS) guidelines for community-acquired pneumonia in hospitalized patients. Chest 1996;110:55S.
33. Hirani NA, MacFarlane JT. Impact of management guidelines on the outcome of severe community acquired pneumonia. Thorax 1997;52:17-21.
34. Niederman MS, Bass JB Jr, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993;148:1418-26.
35. Marrie TJ, Blanchard W. A comparison of nursing home-acquired pneumonia patients with patients with community-acquired pneumonia and nursing home patients without pneumonia. J Am Geriatr Soc 1997;45:50-5.
36. Valenti WM, Trudell RG, Bentley DW. Factors predisposing to oropharyngeal colonization with gram-negative bacilli in the aged. N Engl J Med 1978;298:1108-11.
37. Irwin RS, Whitaker S, Pratter MR, et al. The transiency of oropharyngeal colonization with gram-negative bacilli in residents of a skilled nursing facility. Chest 1982;81:31-5.
38. Marrie TJ. Community-acquired pneumonia. Clin Infect Dis 1994;18:501-15.
39. Marrie TJ, Slayter KL. Nursing home-acquired pneumonia. Treatment options. Drugs Aging 1996;8:338-48.
40. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination levels among adults aged ≥ 65 years - United States, 1997. MMWR Morb Mortal Wkly Rep 1998;47:797-802.
41. Lave JR, Lin CC, Hughes-Cromick P, et al. The cost of treating patients with community-acquired pneumonia. Semin Respir Crit Care Med. In press 1999.
42. Marrie TJ. Epidemiology of community-acquired pneumonia in the elderly. Semin Respir Infect 1990;5:260-8.
43. Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995;333:481-6.
44. Fine MJ, Smith MA, Carson CA, et al. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med 1994;154: 2666-77.
45. Rubins JB, Puri AK, Loch J, et al. Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly patients. J Infect Dis 1998;178:431-40.
46. Chan CY, Molrine DC, George S, et al. Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment for Hodgkin's disease. J Infect Dis 1996;173:256-8.
47. Mufson MA, Krause HE, Schiffman G. Revaccination of pneumococcal vaccine of elderly persons 6 years after primary vaccination. Vaccine 1991;9;403-7.
48. Herman CJ, Speroff T, Cebul RD. Improving compliance with immunization in the older adult: results of a randomized cohort study. J Am Geriatr Soc 1994;42:1154-9.
49. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46(RR-9):1-25.
50. Patriarca PA, Arden NH, Koplan JP, et al. Prevention and control of type A influenza infections in nursing homes. Benefits and costs of four approaches using vaccination and amantadine. Ann Intern Med 1987;107:732-40.
51. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997;175:1-6.